All In Biotech

Drug Trial Radar · NCT05993299

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Evaluation of Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Last checked: Nov 20, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

7

Actual

Start

Dec 31, 2019

Primary completion

Oct 12, 2022

Study completion Mar 17, 2026

Sponsor

Lead sponsor
USWM, LLC (dba US WorldMeds)Industry
Sponsor type
Industry
First posted
Aug 15, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 10 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors. This trial is a sub study of the Master study NCT03967223.

Conditions

  • Neoplasms

Interventions

  • Letetresgene autoleucelDrug

    Letetresgene autoleucel will be administered.

  • CyclophosphamideDrug

    Cyclophosphamide will be used as a lymphodepleting chemotherapy.

  • FludarabineDrug

    Fludarabine will be used as a lymphodepleting chemotherapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR)Time frame: Up to approximately 36 months

Locations

38 sites in 7 countries. Site status is shown where the registry gives one.

  • City of Hope National Medical Center

    Duarte, California

  • Stanford Hospital and Clinics

    Stanford, California

  • Sarah Cannon Research Institute

    Denver, Colorado

  • Mayo Clinic Jacksonville

    Jacksonville, Florida

  • University of Chicago

    Chicago, Illinois

  • University of Iowa College of Medicine

    Iowa City, Iowa

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Michigan Medical Center

    Ann Arbor, Michigan

  • Minnesota Oncology Hematology

    Minneapolis, Minnesota

  • Mayo Clinic Rochester

    Rochester, Minnesota

  • Washington University

    St Louis, Missouri

  • Memorial Sloan Kettering cancer center

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Ohio State University-Columbus

    Columbus, Ohio

  • Oregon Health and Science University

    Portland, Oregon

  • University of Pittsburgh, Hillman Cancer centre

    Pittsburgh, Pennsylvania

  • Tennessee Oncology

    Nashville, Tennessee

  • University Of Texas Southwestern Medical Center

    Dallas, Texas

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • University of Utah

    Salt Lake City, Utah

  • Virginia Commonwealth University

    Richmond, Virginia

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington

  • Froedtert Hospital

    Milwaukee, Wisconsin

  • Princess Margaret Cancer Centre

    Toronto, Canada

  • CIUSSS de L'Est-De-Lile-De-Montreal

    Montreal, Quebec, Canada

  • Centre Léon Bérard

    Lyon, France

  • CHU de Bordeaux GH Sud Hôpital Haut Lévêque

    Pessac, France

  • Fondazione IRCCS Instituto Nazionale Dei Tumori

    Milan, Italy

  • Ircss Istituto Clinico Humanitas

    Romano di Lombardia, Italy

  • The Netherlands Cancer Institute

    Amsterdam, Netherlands

  • Hospital Santa Creu Y Sant Pau

    Barcelona, Spain

  • Ico Duran y Reynals l'Hospitalet de Llobrega

    Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Spain

  • Hospital Virgen Del Rocio

    Seville, Spain

  • Royal Marsden Hospital

    London, United Kingdom

  • University College Hospital-London

    London, United Kingdom

  • Christie Hospital NHS Foundation Trust

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.